Data / Research funding / Missouri / Cryocrate, LLC
Cryocrate, LLC: 5 NIH awards ($6.9M), fiscal years 2021 to 2026
Cryocrate, LLC in Columbia, MO is funded under 5 NIH awards ($6.9M) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- MXHXWLBMUZL7
- State
- Missouri
Awards
5 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery | NIH | Office of the Director, National Institutes of Health | 2024 to 2025 | $1,863,241 | September 15, 2024 | August 31, 2026 | HAN, XU | reporter.nih.gov |
| Innovation of Biobanking for Cellular Adoptive Immunotherapies Based on a First-in-Class Biocompatible Cryopreservation Technology for T and NK Cells and Their CAR-Engineered Products | NIH | National Cancer Institute | 2022 to 2023 | $1,763,086 | September 15, 2022 | August 31, 2025 | HAN, XU | reporter.nih.gov |
| Innovation of Skin Banking and Transplantation Based on a First-in-Class Biocompatible Cryopreservation Technology | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $1,487,801 | May 6, 2022 | April 30, 2025 | HAN, XU | reporter.nih.gov |
| Late-stage Preclinical Development and cGMP Production of a First-in-Class Cornea Cryopreservation Kit Based on FDA Feedback | NIH | National Eye Institute | 2021 to 2022 | $1,480,970 | September 1, 2021 | August 31, 2025 | HAN, XU | reporter.nih.gov |
| Novel Biocompatible, High-Throughput Cryopreservation Medium and Method for Enhanced Post-Thaw Migration and Cytotoxicity of NK Cells | NIH | National Cancer Institute | 2025 | $292,963 | September 17, 2025 | August 31, 2028 | HAN, XU | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 2 | $1,215,383 | 0 | $0 |
| 2024 | 1 | $940,821 | 0 | $0 |
| 2023 | 2 | $1,600,449 | 0 | $0 |
| 2022 | 3 | $2,377,423 | 0 | $0 |
| 2021 | 1 | $753,985 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Topics of its NIH awards
- Bioengineering
- Biotechnology
- Transplantation
- Eye Disease and Disorders of Vision
- Cancer
- Immunotherapy
- Translational Research
- Machine Learning and Artificial Intelligence
- Organ Transplantation
- Induced Pluripotent Stem Cell Research
- Neurosciences
- Regenerative Medicine
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.